Deciphera Pharmaceuticals, Inc. Deferred Tax Assets, Gross
Deciphera Pharmaceuticals, Inc. had Deferred Tax Assets, Gross of $377.07 million as of 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2024-02-07
- 2023-12-31: Deferred Tax Assets, Gross $377.07M.
- 2022-12-31: Deferred Tax Assets, Gross $327.31M.
- 2021-12-31: Deferred Tax Assets, Gross $282.54M.
- 2020-12-31: Deferred Tax Assets, Gross $203.18M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2023-12-31 | $377.07M 10-K · filed 2024-02-07 |
| 2022-12-31 | $327.31M 10-K · filed 2024-02-07 |
| 2021-12-31 | $282.54M 10-K · filed 2023-02-07 |
| 2020-12-31 | $203.18M 10-K · filed 2022-02-08 |
| 2019-12-31 | $119.65M 10-K · filed 2021-02-09 |
| 2018-12-31 | $48.19M 10-K · filed 2020-03-09 |
| 2017-12-31 | $10.84M 10-K · filed 2019-03-14 |